Dr. Sara Y. Gaspard, MD

Dr. Gaspard practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. Gaspard's NPI, 1023253473, was assigned on December 12, 2008. Dr. Gaspard graduated from Keck School of Medicine of USC in 2005. Dr. Gaspard holds California license A97252.

Dr. Gaspard's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. Gaspard's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. Dr. Gaspard is also affiliated with Huntington Hospital. The medical group on file is Comprehensive Dermatology Center of Pasadena. Dmand AI also links Dr. Gaspard to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gaspard practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gaspard's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gaspard is board certified in dermatology by the American Board of Dermatology. Dr. Gaspard is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives, itchy rashes and joint cyst among the conditions Dr. Gaspard treats.

CMS data shows 2,315 Medicare services from Dr. Gaspard across 12 procedure codes in 2024, for 576 Medicare patients. Medicare paid $128,523 for them. Every service was in an office.

CMS counts 576 Medicare patients who saw Dr. Gaspard in 2024. The largest group is 65 to 74, with 289 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gaspard's median patient age at 49, with 65% women.

In 2024, Dr. Gaspard wrote 529 Medicare Part D claims for 220 patients. 86% of them were for generic drugs. CMS names the drug for 358 of them, across 13 drugs with 11 or more claims each, at $202,172 in total drug cost. In 2023, CMS named 386 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Gaspard for performance year 2024, reported individually. Dr. Gaspard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 323 procedures of skin biopsy by Dr. Gaspard, more than 91% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Gaspard in 2021. Dr. Gaspard's most frequent co-authors are Cameron D. Chesnut, MD, Terrence Colin Keaney, MD and Neil Scott Sadick, MD.

CMS Open Payments shows 1,598 general payments to Dr. Gaspard from 47 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Allergan Inc. paid the most, $436,537.

Dmand AI lists 2 awards for Dr. Gaspard, most recently CMS Stage 1 EHR in 2014.

Dr. Gaspard graduated from Keck School of Medicine of USC in 2005. Dr. Gaspard is a member of AAD.

Dr. Gaspard is in network with 11 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.